Literature DB >> 4595271

Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.

H F Hill, A G Hill, A G Mowat, B M Ansell, J A Mathews, M H Seifert, J M Gumpel, G A Christie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4595271      PMCID： PMC1006192          DOI： 10.1136/ard.33.1.12

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Naproxen: a novel approach to dose-finding efficacy trails in rheumatoid arthritis.

Authors:  A Lussier; E J Segre; C V Multz; K MacCannell; S J Alexander; D L Howard; G Boost; J Varady; W Strauss
Journal:  Clin Pharmacol Ther       Date:  1973 May-Jun       Impact factor: 6.875

2.  Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors:  P L Boardman; F D Hart
Journal:  Br Med J       Date:  1967-11-04

3.  Nonsteroidal antiinflammatory agents. I. 6-substituted 2-naphthylacetic acids.

Authors:  I T Harrison; B Lewis; P Nelson; W Rooks; A Roszkowski; A Tomolonis; J H Fried
Journal:  J Med Chem       Date:  1970-03       Impact factor: 7.446

4.  Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects.

Authors:  P Donnelly; K Lloyd; H Campbell
Journal:  Br Med J       Date:  1967-01-14

5.  Assessment of drugs in out-patients with rheumatoid arthritis. Evaluation of methods and a comparison of mefenamic and flufenamic acids with phenylbutazone and aspirin.

Authors:  R M Mason; D E Barnardo; W R Fox; M Weatherall
Journal:  Ann Rheum Dis       Date:  1967-09       Impact factor: 19.103

6.  Anti-inflammatory and analgetic properties of d-2-(6'-methoxy-2'-naphthyl)-propionic acid (naproxen).

Authors:  A P Roszkowski; W H Rooks; A J Tomolonis; L M Miller
Journal:  J Pharmacol Exp Ther       Date:  1971-10       Impact factor: 4.030
  6 in total
  9 in total

1.  The new antirheumatic drugs.

Authors:  F D Hart
Journal:  Drugs       Date:  1975       Impact factor: 9.546

2.  A review of upper-gastrointestinal effects of the newer nonsteroidal antiinflammatory agents.

Authors:  R E Pemberton; L J Strand
Journal:  Dig Dis Sci       Date:  1979-01       Impact factor: 3.199

3.  Double-blind trial of naproxen and phenylbutazone in ankylosing spondylitis.

Authors:  F Van Gerwen; J K Van der Korst; F W Gribnau
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

4.  Incidence of gastric side effects in controlled trials with unbranded aspirin and with various long-acting aspirin preparations.

Authors:  J M Gumpel
Journal:  Ann Rheum Dis       Date:  1978-08       Impact factor: 19.103

5.  Naproxen in juvenile chronic polyarthritis.

Authors:  H Moran; D B Hanna; B M Ansell; M Hall; C Engler
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

6.  Naproxen in osteoarthrosis. Double-blind crossover trial.

Authors:  W Blechman; R Willkens; G L Boncaldo; R T Hoffmeister; L M Lockie; C Multz
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

Review 7.  Ototoxicity associated with salicylates. A brief review.

Authors:  J A Brien
Journal:  Drug Saf       Date:  1993-08       Impact factor: 5.606

8.  Multicentre trial of naproxen and phenylbutazone in acute gout.

Authors:  R A Sturge; J T Scott; E B Hamilton; S P Liyanage; A S Dixon; J Davies; C Engler
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

9.  Letter: Naproxen (naprosyn) and gastrointestinal haemorrhage.

Authors: 
Journal:  Br Med J       Date:  1974-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.